First slide

The world’s leading chemical company Evonik has announced the acquisition of Princeton based Wilshire Technologies, a leading supplier of phytochemicals and derivatives to the global cosmetic and pharmaceutical industries. The transaction also includes Wilshire Technologies employees, and cosmetic active ingredients portfolio.

The acquisition of Wilshire Technologies will enhance Evonik’s Care Solutions business into phytochemicals, such as plant derived cholesterol, as a replacement for animal originated ingredients in cosmetic active ingredients. The deal also helps the ongoing transformation of Evonik’s cosmetics ingredients portfolio towards sustainability and natural-based ingredient.

 

The prominent acquisitions and expansion by Evonik are mentioned below:

February 2020: Evonik has closed the acquisition of the US company PeroxyChem for US$640 million. PeroxyChem is a leading manufacturer of hydrogen peroxide (H2O2) and peracetic acid (PAA) and is well-positioned in high-margin specialty applications.

December 2019: Evonik announced its strategy to increase the capacity of sodium methylate at its Rosario/Santa Fe facility from 60,000 metric tons up to 90,000 metric tons by 2021. Sodium methylate is an important catalyst for large-scale biodiesel production.

September 2019: Evonik, announced the acquisition of the Endexo a surface modification business of Toronto based Interface Biologics, a privately-held material science company. The deal has strengthened the medical device capabilities of the company.

About Evonik

Evonik, headquartered at Essen, North Rhine-Westphalia, Germany, is one of the world’s leading specialty chemicals companies. The company is operating in more than 100 countries, and employing approximately 36,000 people across the world. The company’s product makes tires fuel-efficient, mattresses more elastic, medications more effective, and animal feeds healthier. Evonik, provides biomaterials for use in medical implant applications.

Related News